NCT00058253 2014-06-17
Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Infinity Pharmaceuticals, Inc.